Question · Q4 2025
Stephen C. Baxter sought a deeper understanding of the decremental margins on HIX revenue loss, questioning why the drop-through wouldn't be higher given potential continued ER utilization without associated revenue, and asked what percentage of HIX enrollment loss is assumed to transition to other coverage sources. He also asked about the same-store volume growth assumption for 2026 guidance and which payer categories are expected to drive improvement compared to 2025.
Answer
CFO Jason Johnson stated it's too early to accurately predict patient transitions (self-pay, downgrade, other coverage). CEO Kevin Hammons reiterated that the company generates a relatively low margin on HIX business, and some patients may gain better commercial or Medicaid coverage, while others become uninsured, justifying the 20%-30% EBITDA hit. CFO Jason Johnson indicated a low single-digit same-store volume growth expectation for 2026. CEO Kevin Hammons specified that commercial payer volumes are expected to improve, along with additional Medicare business, driven by capital and service line investments.
Ask follow-up questions
Fintool can predict
CYH's earnings beat/miss a week before the call